News
Dispatches from the runway.
Jetstream Invests in Rejuvenation Technologies
- What if aging cells could regain their ability to repair? Imagine a future where cells damaged by age could regain some of their ability to divide and repair tissue.Where pulmonary fibrosis, liver disease, bone marrow failure, and other serious conditions could potentially be addressed by restoring a mechanism cells gradually [read more]
Why We Believe Carbogenesis Could Transform Clean Technology
- At Xcellerant Ventures, we believe the most transformative technologies don’t succeed because they simply address a problem—they succeed because they create a better solution. The companies that change the world are the ones that make the impossible practical. They solve real challenges, create economic value, and become the obvious choice [read more]
Jetstream Invests in Moonrise Medical
- An AI-powered ultrasound platform that automates vascular diagnostics for peripheral artery disease and diabetic foot wounds, delivering lab-grade results in as little as 25 seconds without a specialized sonographer. Summary Moonrise Medical is a Hamilton, Ontario-based medtech company building an AI-powered ultrasound platform that automates vascular diagnostics for peripheral artery [read more]
Jetstream Invests in ImageAiD
- A noninvasive, AI-powered Doppler platform designed to catch peripheral artery disease years before symptoms appear. Summary ImageAiD is a medical technology company developing a portable, point-of-care Doppler ultrasound platform aimed at closing a longstanding gap in vascular diagnostics. Current screening relies heavily on ankle-brachial index (ABI) testing, which can produce [read more]
Why We Invested in Hill Research: Reimagining Clinical Development with AI
- Throughout my career as an emergency physician, entrepreneur, and investor, I’ve seen firsthand how difficult it is to bring new therapies to patients. Scientific breakthroughs often capture the headlines, but behind every successful treatment is an incredibly complex clinical development process—one that demands precision, regulatory rigor, and countless hours of [read more]
You Shouldn’t Have to Wait Seven Years to Know Your Investment Is Working
- Traditional venture capital asks a lot of its investors. You write a check, you wait a decade, and somewhere in year nine or ten, you find out how it went. No updates that change the math. No liquidity. No signal that the thesis is playing out. Just patience — compulsory [read more]
FEATURED ON
THE TEAM
Meet the Crew
We follow a people-first philosophy, grounded in the belief that empowering visionary entrepreneurs drives transformative change across industries. Through strategic partnerships with leading organizations, foundations, and institutions, we amplify our impact and maximize opportunities for innovation. Beyond capital, we provide tailored mentorship and guidance, equipping our portfolio companies with the tools to thrive and redefine the future.
